Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Esophageal Dysmotility and Dilatation After Laparoscopic Gastric Banding

This study has been completed.
Sponsor:
Collaborator:
Department of Medicine, Spital STS AG Thun
Information provided by:
Spital STS AG
ClinicalTrials.gov Identifier:
NCT01234428
First received: November 2, 2010
Last updated: NA
Last verified: November 2010
History: No changes posted

November 2, 2010
November 2, 2010
June 1998
June 2009   (final data collection date for primary outcome measure)
esophageal dilatation [ Time Frame: yearly follow-up over 12 year period ] [ Designated as safety issue: No ]
esophageal dilatation or dysfunction
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Esophageal Dysmotility and Dilatation After Laparoscopic Gastric Banding
Esophageal Dysmotility Disorders Following Laparoscopic Gastric Banding - An Underestimated Complication.

The purpose of this study is to determine whether esophageal dysmotility and dilatation is an important complication in the long term follow-up following laparoscopic gastric banding for morbid obesity.

Using a yearly barium swallow the diameter of the esophagus will be monitored over the period.

Interventional
Not Provided
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Esophageal Motility Disorders
  • Procedure: Laparoscopic surgery
    Gastric banding
    Other Name: laparoscopic surgery
  • Procedure: gastric banding
    laparoscopic gastric banding
    Other Name: morbid obesity
surgery
Interventions:
  • Procedure: Laparoscopic surgery
  • Procedure: gastric banding
Naef M, Mouton WG, Naef U, van der Weg B, Maddern GJ, Wagner HE. Esophageal dysmotility disorders after laparoscopic gastric banding--an underestimated complication. Ann Surg. 2011 Feb;253(2):285-90. doi: 10.1097/SLA.0b013e318206843e.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
167
March 2010
June 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • BMI more than 40

Exclusion Criteria:

  • BMI below 40
Both
18 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
NCT01234428
MOB-12-STS-AG
No
Markus Naef, MD, MBA, Department of Surgery, Spital STS AG Thun, Switzerland
Spital STS AG
Department of Medicine, Spital STS AG Thun
Principal Investigator: Markus Naef, MD, MBA Spital STS AG Thun, Switzerland
Spital STS AG
November 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP